STOCK TITAN

CV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

CV Sciences (OTCQB:CVSI), a consumer wellness company focused on hemp extracts and natural ingredients, has scheduled its Year End and Fourth Quarter 2024 financial results announcement for March 27, 2025, before market opening.

The company will host a conference call with investors at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time) on the same day. Investors can participate through a webcast available on the company's Investor Relations website or by dialing (877) 407-0784 for U.S. callers or (201) 689-8560 for international participants.

A replay of the call will be accessible until April 3, 2025, by dialing (844) 512-2921 (U.S.) or (412) 317-6671 (international) with confirmation code 13752212.

CV Sciences (OTCQB:CVSI), un'azienda di benessere dei consumatori focalizzata su estratti di canapa e ingredienti naturali, ha programmato l'annuncio dei risultati finanziari per il Year End e il Quarto Trimestre 2024 per il 27 marzo 2025, prima dell'apertura del mercato.

L'azienda ospiterà una conference call con gli investitori alle 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time) lo stesso giorno. Gli investitori possono partecipare tramite un webcast disponibile sul sito web delle Relazioni con gli Investitori dell'azienda o chiamando il numero (877) 407-0784 per i chiamanti statunitensi o (201) 689-8560 per i partecipanti internazionali.

Una registrazione della chiamata sarà accessibile fino al 3 aprile 2025, componendo il numero (844) 512-2921 (U.S.) o (412) 317-6671 (internazionale) con il codice di conferma 13752212.

CV Sciences (OTCQB:CVSI), una empresa de bienestar del consumidor centrada en extractos de cáñamo e ingredientes naturales, ha programado el anuncio de sus resultados financieros para el Año Fiscal y Cuarto Trimestre 2024 para el 27 de marzo de 2025, antes de la apertura del mercado.

La empresa llevará a cabo una conferencia telefónica con inversores a las 7:00 a.m. Hora del Pacífico (10:00 a.m. Hora del Este) el mismo día. Los inversores pueden participar a través de un webcast disponible en el sitio web de Relaciones con Inversores de la empresa o llamando al (877) 407-0784 para los llamantes de EE. UU. o al (201) 689-8560 para los participantes internacionales.

Una repetición de la llamada estará accesible hasta el 3 de abril de 2025, llamando al (844) 512-2921 (EE. UU.) o al (412) 317-6671 (internacional) con el código de confirmación 13752212.

CV Sciences (OTCQB:CVSI)는 대마 추출물과 자연 성분에 중점을 둔 소비자 웰니스 회사로, 2024 회계연도 및 4분기 재무 결과 발표를 2025년 3월 27일 시장 개장 전에 예정하고 있습니다.

회사는 같은 날 오전 7:00 태평양 표준시 (오전 10:00 동부 표준시)에 투자자와의 컨퍼런스 콜을 개최할 것입니다. 투자자들은 회사의 투자자 관계 웹사이트에서 제공되는 웹캐스트를 통해 참여하거나, 미국 전화 발신자는 (877) 407-0784로, 국제 참가자는 (201) 689-8560으로 전화하여 참여할 수 있습니다.

전화 통화의 재생은 2025년 4월 3일까지 (미국) (844) 512-2921 또는 (국제) (412) 317-6671로 전화하여 확인 코드 13752212로 접근할 수 있습니다.

CV Sciences (OTCQB:CVSI), une entreprise de bien-être des consommateurs axée sur les extraits de chanvre et les ingrédients naturels, a prévu l'annonce de ses résultats financiers pour la fin d'année et le quatrième trimestre 2024 pour le 27 mars 2025, avant l'ouverture du marché.

L'entreprise organisera une conférence téléphonique avec les investisseurs à 7h00 heure du Pacifique (10h00 heure de l'Est) le même jour. Les investisseurs peuvent participer via un webinaire disponible sur le site web des Relations avec les Investisseurs de l'entreprise ou en composant le (877) 407-0784 pour les appelants américains ou le (201) 689-8560 pour les participants internationaux.

Une rediffusion de l'appel sera accessible jusqu'au 3 avril 2025 en composant le (844) 512-2921 (États-Unis) ou le (412) 317-6671 (international) avec le code de confirmation 13752212.

CV Sciences (OTCQB:CVSI), ein Verbraucher-Wellness-Unternehmen, das sich auf Hanfextrakte und natürliche Inhaltsstoffe konzentriert, hat die Bekanntgabe seiner finanziellen Ergebnisse für das Jahresende und das vierte Quartal 2024 für den 27. März 2025 vor Markteröffnung angesetzt.

Das Unternehmen wird am selben Tag um 7:00 Uhr Pazifischer Zeit (10:00 Uhr Eastern Time) eine Telefonkonferenz mit Investoren abhalten. Investoren können über ein Webcast teilnehmen, das auf der Website für Investor Relations des Unternehmens verfügbar ist, oder indem sie (877) 407-0784 für Anrufer aus den USA oder (201) 689-8560 für internationale Teilnehmer anrufen.

Eine Wiederholung des Anrufs wird bis zum 3. April 2025 unter (844) 512-2921 (USA) oder (412) 317-6671 (international) mit dem Bestätigungscode 13752212 zugänglich sein.

Positive
  • None.
Negative
  • None.

SAN DIEGO, CALIFORNIA / ACCESS Newswire / March 20, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced that it will release financial results for the year end and fourth quarter ended December 31, 2024, before the stock market opens on Thursday, March 27, 2025. The Company will hold a conference call with the investment community at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time) that same day.

The webcast of the conference call will be available on the Investor Relations section of the Company's website at https://ir.cvsciences.com/news-events or directly at https://viavid.webcasts.com/starthere.jsp?ei=1710928&tp_key=ccf1cdb9ed. The webcast will be archived for approximately 30 days. Investors interested in participating in the live call can also dial (877) 407-0784 from the U.S. or international callers can dial (201) 689-8560. Please dial the conference telephone number 15 minutes prior to the start time due to increased demand for conference calls.

A telephone replay will be available approximately two hours after the call concludes and will be available through Thursday, April 3, 2025, by dialing (844) 512-2921 from the U.S. or (412) 317-6671 from international locations, and entering confirmation code 13752212.

About CV Sciences, Inc.

CV Sciences, Inc. (OTCQB:CVSI) is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company's hemp extracts and other proven, science-backed, natural ingredients and products are sold through a range of sales channels from B2B to B2C. The Company's +PlusCBD™ branded products are sold at select retail locations throughout the U.S. and are the top-selling hemp-extract brand in the natural products market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry. With a commitment to science, PlusCBD™ product benefits in healthy people are supported by human clinical research data, in addition to three published clinical case studies available on PubMed.gov. +PlusCBD™ was the first hemp extract supplement brand to invest in the scientific evidence necessary to receive self-affirmed Generally Recognized as Safe (GRAS) status. The Company also produces cannabinoid-free supplements under its +PlusHLTH™ brand, with targeted formulations to optimize health, improve performance, and increase vitality. Our Cultured Foods™ brand provides a variety of 100% plant-based food products that are distributed primarily in the EU and other select markets. Cultured Foods™ caters to individuals seeking vegan, gluten-free, or flexitarian options for a wholesome and satisfying culinary experience. In addition, the Company owns Elevated Softgels, a leading manufacturer of encapsulated softgels and tinctures for the supplement and nutrition industry. CV Sciences, Inc. has primary offices and facilities in San Diego, California, Grand Junction, Colorado, and Warsaw, Poland. Additional information is available from OTCMarkets.com or by visiting www.cvsciences.com.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risk and uncertainties. CV Sciences does not undertake any obligation to publicly update any forward-looking statements, except as required by applicable law. As a result, investors should not place undue reliance on such forward-looking statements.

CONTACT INFORMATION:

ir@cvsciences.com

SOURCE: CV Sciences, Inc.



View the original press release on ACCESS Newswire

FAQ

When will CV Sciences (CVSI) release its Q4 and full-year 2024 earnings?

CV Sciences will release its Q4 and full-year 2024 earnings on March 27, 2025, before the stock market opens.

How can investors join CV Sciences' (CVSI) Q4 2024 earnings call?

Investors can join via webcast at ir.cvsciences.com or dial (877) 407-0784 (U.S.) or (201) 689-8560 (international) at 7:00 a.m. PT/10:00 a.m. ET.

Until when will CV Sciences' (CVSI) Q4 2024 earnings call replay be available?

The earnings call replay will be available until April 3, 2025, accessible by dialing (844) 512-2921 (U.S.) or (412) 317-6671 (international).

Where can I access the webcast of CV Sciences' (CVSI) Q4 2024 earnings call?

The webcast will be available on CV Sciences' Investor Relations website and will be archived for approximately 30 days.
Cv Sciences

OTC:CVSI

CVSI Rankings

CVSI Latest News

CVSI Stock Data

5.71M
184.23M
0.02%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
San Diego